je.st
news
Tag: tablet
Xplore Guns For Military & Government With Rugged New Windows 7 Tablet
2013-04-01 06:48:44| dairynetwork News Articles
Rugged tablet maker Xplore Technologies isn’t ready to give up to the iPad or Microsoft’s Surface when it comes to tablet deployments in government or military.
Tags: windows
government
military
guns
Merck: FDA Reviewing Tablet to Eliminate Allergy
2013-03-28 17:38:48| Biotech - Topix.net
Drugmaker Merck & Co. said Wednesday that federal regulators are reviewing its application to sell a new type of treatment for grass pollen allergy that gradually reduces allergy symptoms over time, rather than just temporarily relieving the sneezing and itching.
Tags: eliminate
reviewing
tablet
allergy
Xplore Introduces The New iX104C5-M2 Rugged Tablet For Military And Government Personnel
2013-03-28 12:06:44| dairynetwork News Articles
Xplore Technologies Corp. (NASDAQ: XPLR), the manufacturer of the world’s most powerful, longest-lasting and rugged tablet in the market, has announced the newest addition to its rugged tablet portfolio, the iX104C5-M2.
Tags: government
military
personnel
introduces
Merck: FDA reviewing tablet to eliminate allergy
2013-03-27 18:30:45| Biotech - Topix.net
Drugmaker Merck & Co. says federal regulators are reviewing its application to sell a new type of treatment for grass pollen allergy that gradually reduces allergy symptoms over time, rather than just temporarily relieving the sneezing and itching.
Tags: eliminate
reviewing
tablet
allergy
Merck Announces FDA Acceptance of Biologics License Application for Investigational Grass Pollen Allergy Immunotherapy Tablet
2013-03-27 13:00:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Biologics License Application (BLA) for its investigational Timothy grass pollen (Phleum pratense) allergy immunotherapy tablet (AIT) has been accepted for review by the U.S. Food and Drug Administration (FDA). In March, the company also submitted a BLA to the FDA for its investigational ragweed pollen (Ambrosia artemisiifolia) AIT. Language: English Contact HTML: MerckMedia:Pam Eisele, (908) 423-5042Tracy Ogden, (267) 305-2301orInvestors:Justin Holko, (908) 423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: application
license
acceptance
grass
Sites : [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] next »